CJC-1295 / Ipamorelin vs Ipamorelin
CJC-1295 / Ipamorelin and Ipamorelin are both studied in longevity research, but they are different classes of compound with different reported research applications.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do CJC-1295 / Ipamorelin and Ipamorelin differ?
CJC-1295 / Ipamorelin (Co-formulated GHRH-analog and secretagogue blend) is catalogued under longevity & cellular research; Ipamorelin (Synthetic pentapeptide secretagogue) is catalogued under longevity & cellular research. Verve lists 5 reported research applications for CJC-1295 / Ipamorelin and 5 for Ipamorelin. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | CJC-1295 / Ipamorelin | Ipamorelin |
|---|---|---|
| compound class | Co-formulated GHRH-analog and secretagogue blend | Synthetic pentapeptide secretagogue |
| research area | longevity & cellular | longevity & cellular |
| reported research applications | 5 listed | 5 listed |
| supplied as | co-formulated blend | single compound |
| catalog sizes | 10mg | 5mg · 10mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | available | available |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $157.49 | $64.99 |
| availability | in stock | out of stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is CJC-1295 / Ipamorelin and what is Ipamorelin?
CJC-1295 / Ipamorelin is classified as Co-formulated GHRH-analog and secretagogue blend; Ipamorelin as Synthetic pentapeptide secretagogue. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
CJC-1295 / Ipamorelin
Co-formulated GHRH-analog and secretagogue blend
CJC-1295 / Ipamorelin is a co-formulated research blend of two peptides that act at separate receptors. CJC-1295 without DAC, also referred to as Mod GRF 1-29, is a modified 29-amino-acid analog of growth-hormone-releasing hormone characterized as a GHRH-receptor agonist. Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the growth-hormone secretagogue receptor, GHS-R1a.
full CJC-1295 / Ipamorelin profile →Ipamorelin
Synthetic pentapeptide secretagogue
Ipamorelin is a synthetic pentapeptide and a selective growth-hormone secretagogue, meaning it is characterized in the literature as an agonist at the growth-hormone secretagogue receptor (GHS-R1a), the same receptor targeted by the endogenous ligand ghrelin. Its selectivity profile is the reason it is so frequently chosen as a reference agonist in receptor-signaling work.
full Ipamorelin profile →Which research models is each compound studied in?
CJC-1295 / Ipamorelin and Ipamorelin both sit inside longevity & cellular research, so their listed models share framing while differing in specifics. The table lists 5 reported research applications for CJC-1295 / Ipamorelin and 5 for Ipamorelin. Rows are per compound, not equivalences.
| CJC-1295 / Ipamorelin — reported research applications | Ipamorelin — reported research applications |
|---|---|
| Dual-pathway GHRH-receptor and GHS-R1a signaling research | GHS-R1a (ghrelin receptor) binding and agonist research |
| Receptor cross-talk and signal-transduction research models | Secretagogue-pathway signal-transduction research |
| Comparative agonist research versus single-component preparations | Comparative receptor-selectivity studies against non-selective secretagogues |
| Endocrine-signaling research in cellular and pre-clinical models | Endocrine-signaling research models |
| Peptide stability and analog structure–activity research | Peptide stability and structure–activity research |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for CJC-1295 / Ipamorelin and Ipamorelin?
CJC-1295 / Ipamorelin is listed from $157.49 and Ipamorelin from $64.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| CJC-1295 / Ipamorelin | 10mg | $157.49 | in stock |
| Ipamorelin | 5mg | $64.99 | out of stock |
| Ipamorelin | 10mg | $114.49 | out of stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about CJC-1295 / Ipamorelin and Ipamorelin
What is CJC-1295 / Ipamorelin?
It is a co-formulated research blend of CJC-1295 without DAC (also called Mod GRF 1-29), a GHRH analog, and ipamorelin, a selective GHS-R1a agonist. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is the difference between CJC-1295 with and without DAC?
The DAC (drug affinity complex) modification is a chemical addition studied for its effect on the analog's circulating half-life in pre-clinical models. The no-DAC form, Mod GRF 1-29, lacks that modification and is the component used in this blend.
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the growth-hormone secretagogue receptor (GHS-R1a). Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is Ipamorelin studied for in research?
It is used as a reference agonist in GHS-R1a receptor-binding and secretagogue-pathway signaling research in in-vitro and pre-clinical models. Verve makes no claims about effects in humans or animals.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.